Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: ICON | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News, Promotions & Moves

Financial Report: ICON

Revenues up 5%, CFO named

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ICON

4Q Revenues: $243.0 million (+5%)

4Q Earnings: $4.1 million (-81%)

FY Revenues: $946.0 million (+5%)

FY Earnings: $31.5 million (-64%)  

Comments: Business awards in the quarter were $308 million, a book-to-bill of 1.3. For the year, new business awards were $1.3 billion, a book-to-bill of 1.4. Also, Brendan Brennan has been appointed chief financial officer at ICON. Mr. Brennan has served as acting chief financial officer since October 2011. Previously he served as ICON’s senior vice president of corporate finance and has been a senior member finance team since January 2006. Prior to joining ICON, Mr. Brennan held a senior corporate finance position in CRH plc, an international building materials group.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters